knowledge -WSS

knowledge

author：explore 2025-10-01 00:58:52 - browse：116

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Sanders adds drug shortage policies to pandemic preparedness bill

entertainment

WSS

Stem cell clinics for heart failure: buyer be wary

How dance can help nurses traumatized by Covid

STAT Virtual Event: The State of Biosimilars: What to Watch

How dance can help nurses traumatized by Covid

Listen: Wegovy in the brain & pivotal Alzheimer's data

White House drug shortage group privately met with industry

hotspot

knowledge

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Custom gene therapy hints at new path for rare disease treatments

Drug repurposing or repositioning? The language matters

Biden tests positive for Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

WHO calls for emergency meeting on new China virus, as cases spread

Medical records are filled with copy

At Orexo, a ‘turning point’ for everything but digital health

Anesthesiologist group: stop taking Ozempic before surgery

Biden tests positive for Covid

Wikipedia

FDA approves RSV monoclonal antibody for infants, toddlers

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

WHO calls for emergency meeting on new China virus, as cases spread

A public scorecard can help hold safety

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

In early work, researchers turn to CRISPR to treat Alzheimer's

leisure time

leisure time

entertainment

leisure time